| Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer S Waalkes, F Atschekzei, MW Kramer, J Hennenlotter, G Vetter, ... BMC cancer 10, 1-6, 2010 | 139 | 2010 |
| Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations T Lorenzini, M Fliegauf, N Klammer, N Frede, M Proietti, A Bulashevska, ... Journal of Allergy and Clinical Immunology 146 (4), 901-911, 2020 | 107 | 2020 |
| The German national registry of primary immunodeficiencies (2012–2017) SM El-Helou, AK Biegner, S Bode, SR Ehl, M Heeg, ME Maccari, ... Frontiers in immunology 10, 1272, 2019 | 107 | 2019 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 102 | 2021 |
| Therapeutic options for CTLA-4 insufficiency D Egg, IC Rump, N Mitsuiki, J Rojas-Restrepo, ME Maccari, C Schwab, ... Journal of Allergy and Clinical Immunology 149 (2), 736-746, 2022 | 86 | 2022 |
| Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells J Li, SF Jørgensen, SM Maggadottir, M Bakay, K Warnatz, J Glessner, ... Nature communications 6 (1), 6804, 2015 | 80 | 2015 |
| Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome JW Leiding, TP Vogel, VGJ Santarlas, R Mhaskar, MR Smith, A Carisey, ... Journal of allergy and clinical immunology 151 (4), 1081-1095, 2023 | 59 | 2023 |
| Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity G Sogkas, F Atschekzei, IR Adriawan, N Dubrowinskaja, T Witte, ... Cellular & Molecular Immunology 18 (5), 1122-1140, 2021 | 59 | 2021 |
| Primary immunodeficiency disorder caused by phosphoinositide 3–kinase δ deficiency G Sogkas, M Fedchenko, A Dhingra, A Jablonka, RE Schmidt, ... Journal of Allergy and Clinical Immunology 142 (5), 1650-1653. e2, 2018 | 56 | 2018 |
| SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence F Atschekzei, J Hennenlotter, S Jänisch, A Großhennig, W Tränkenschuh, ... Epigenetics 7 (5), 447-457, 2012 | 53 | 2012 |
| GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression. I Peters, H Eggers, F Atschekzei, J Hennenlotter, S Waalkes, ... BJU international 110, 2012 | 42 | 2012 |
| Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1 C Schröder, G Sogkas, M Fliegauf, T Dörk, D Liu, LG Hanitsch, S Steiner, ... Frontiers in Immunology 10, 2618, 2019 | 41 | 2019 |
| Prevalence and clinical challenges among adult primary immunodeficiency patients with RAG deficiency D Lawless, CB Geier, JR Farmer, HA Lango, D Thwaites, F Atschekzei, ... The Journal of allergy and clinical immunology 141 (6), 2303, 2018 | 40 | 2018 |
| The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti‐angiogenic signaling pathways H Tezval, S Jurk, F Atschekzei, J Serth, MA Kuczyk, AS Merseburger The Prostate 69 (4), 443-448, 2009 | 39 | 2009 |
| Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy C Schröder, NT Baerlecken, U Pannicke, T Dörk, T Witte, R Jacobs, ... Clinical Immunology 179, 1-7, 2017 | 35 | 2017 |
| Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome G Sogkas, S Hirsch, A Jablonka, T Witte, RE Schmidt, F Atschekzei Clinical immunology (Orlando, Fla.) 215, 108452, 2020 | 34 | 2020 |
| Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation H Tezval, S Jurk, F Atschekzei, JU Becker, O Jahn, J Serth, MA Kuczyk World journal of urology 27, 825-830, 2009 | 34 | 2009 |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency T Le Voyer, AV Parent, X Liu, A Cederholm, A Gervais, J Rosain, ... Nature 623 (7988), 803-813, 2023 | 32 | 2023 |
| A Novel CARMIL2 Mutation Resulting in Combined Immunodeficiency Manifesting with Dermatitis, Fungal, and Viral Skin Infections As Well as Selective Antibody … F Atschekzei, R Jacobs, M Wetzke, G Sogkas, C Schröder, G Ahrenstorf, ... Journal of Clinical Immunology 39, 274-276, 2019 | 28 | 2019 |
| Tumor specific epigenetic silencing of corticotropin releasing hormone-binding protein in renal cell carcinoma: association of hypermethylation and metastasis H Tezval, N Dubrowinskaja, I Peters, C Reese, K Serth, F Atschekzei, ... PloS one 11 (10), e0163873, 2016 | 24 | 2016 |
Georgios SogkasAssociate Professor of Clinical Immunology, Hannover Medical School在 mh-hannover.de 的电子邮件经过验证
Georgios SogkasAssociate Professor of Clinical Immunology, Hannover Medical School在 mh-hannover.de 的电子邮件经过验证